Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial

Documenti analoghi

• Virological and Clinical Outcomes of Influenza Outpatients Treated With Baloxavir, Oseltamivir, or Laninamivir in the 2023–2024 Season
  di: Takeyuki Goto, et al.
  Pubblicazione: (2024)
• Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost‐Effectiveness Analysis
  di: Ruohan Chen, et al.
  Pubblicazione: (2026)
• Obesity in Recovery From Influenza‐Like Illness and Effectiveness of Oseltamivir
  di: Oanh Ngoc Nguyen, et al.
  Pubblicazione: (2025)
• Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV
  di: Atsuko Yamamoto, et al.
  Pubblicazione: (2024)
• Costs of Influenza Illness and Acute Respiratory Infections by Household Income Level: Catastrophic Health Expenditures and Implications for Health Equity
  di: Natalie Wodniak, et al.
  Pubblicazione: (2025)